Citigroup
EXAS

Citigroup’s Exact Sciences EXAS Stock Holding History

Citigroup’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-75,000
Closed -$3.25M – 5726
2025
Q1 		$3.25M Buy
+75,000
New +$3.8M ﹤0.01% 2291
2024
Q4 		– Sell
-5,000
Closed -$341K – 5873
2024
Q3 		$341K Sell
5,000
-182,500
-97% -$10.3M ﹤0.01% 3984
2024
Q2 		$7.92M Sell
187,500
-7,900
-4% -$435K 0.01% 1379
2024
Q1 		$13.5M Buy
+195,400
New +$12.4M 0.01% 1078
2023
Q1 		– Sell
-50,000
Closed -$2.48M – 5607
2022
Q4 		$2.48M Buy
50,000
+15,900
+47% +$650K ﹤0.01% 1878
2022
Q3 		$1.11M Buy
34,100
+14,100
+71% +$581K ﹤0.01% 2638
2022
Q2 		$788K Buy
+20,000
New +$1.07M ﹤0.01% 2868
2021
Q1 		– Sell
-101,000
Closed -$13.4M – 6595
2020
Q4 		$13.4M Sell
101,000
-4,900
-5% -$593K 0.01% 1325
2020
Q3 		$10.8M Sell
105,900
-7,300
-6% -$630K 0.01% 1316
2020
Q2 		$9.84M Buy
113,200
+31,445
+38% +$2.51M 0.01% 1298
2020
Q1 		$4.74M Sell
81,755
-36,000
-31% -$2.92M ﹤0.01% 1717
2019
Q4 		$10.9M Sell
117,755
-35,045
-23% -$3.08M 0.01% 1422
2019
Q3 		$13.8M Buy
152,800
+81,700
+115% +$9.31M 0.01% 1170
2019
Q2 		$8.39M Buy
71,100
+24,900
+54% +$2.51M 0.01% 1525
2019
Q1 		$4M Buy
46,200
+6,800
+17% +$579K ﹤0.01% 1986
2018
Q4 		$2.49M Sell
39,400
-76,000
-66% -$5.22M ﹤0.01% 2460
2018
Q3 		$9.11M Sell
115,400
-12,000
-9% -$783K 0.01% 1351
2018
Q2 		$7.62M Buy
127,400
+108,800
+585% +$5.86M 0.01% 1486
2018
Q1 		$750K Buy
18,600
+5,900
+46% +$288K ﹤0.01% 3547
2017
Q4 		$667K Sell
12,700
-4,300
-25% -$230K ﹤0.01% 3785
2017
Q3 		$801K Sell
17,000
-6,900
-29% -$278K ﹤0.01% 3615
2017
Q2 		$845K Buy
23,900
+11,800
+98% +$364K ﹤0.01% 3486
2017
Q1 		$286K Sell
12,100
-2,700
-18% -$53.5K ﹤0.01% 4350
2016
Q4 		$198K Buy
14,800
+7,200
+95% +$116K ﹤0.01% 5280
2016
Q3 		$141K Sell
7,600
-2,400
-24% -$42.3K ﹤0.01% 4946
2016
Q2 		$123K Buy
10,000
+5,600
+127% +$42.2K ﹤0.01% 4913
2016
Q1 		$30K Sell
4,400
-1,700
-28% -$10.9K ﹤0.01% 6354
2015
Q4 		$56K Hold
6,100
– – ﹤0.01% 5850
2015
Q3 		$110K Sell
6,100
-3,200
-34% -$73.5K ﹤0.01% 4909
2015
Q2 		$277K Buy
9,300
+6,500
+232% +$163K ﹤0.01% 4184
2015
Q1 		$62K Buy
+2,800
New +$71K ﹤0.01% 5391

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Citigroup's EXAS Position: Q1 2026 in Review

Citigroup sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 146,862 shares — an estimated $14.9M sold.

Citigroup first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $110M in Q4 2017. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Citigroup reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Citigroup sold 146,862 Exact Sciences shares in Q1 2026, an estimated $14.9M.
  • Citigroup first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • Citigroup's Exact Sciences position peaked at $110M in Q4 2017.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.